EGFR and lung cancer: Although CD155 was not significantly correlated with PD-L1 expression in the entire population, CD155high was associated with higher PD-L1 positivity in the oncogene-mutated subsets (ALK and EGFR alterations), which is concordant with studies in early-stage lung cancer [1].